Anti-C1q antibodies in patients with systemic lupus erythematosus treated by rituximab

AIM: To determine the time course of changes in the blood levels of antibodies (Ab) to complement component C1q (a-C1q) in patients with systemic lupus erythematosus (SLE) during rituximab (RTM) therapy and the association with organ injuries in SLE/MATERIAL AND METHODS: The study involved 41 patien...

Full description

Bibliographic Details
Main Authors: M É Tsanian, A V Torgashina, E N Aleksandrova, S K Solov'ev, E L Nasonov
Format: Article
Language:Russian
Published: "Consilium Medicum" Publishing house 2013-05-01
Series:Терапевтический архив
Subjects:
Online Access:https://ter-arkhiv.ru/0040-3660/article/view/31281